3 ms·
Yup. Moderna doesn’t have much to worry about. Most of the volume of vaccine will be sold in the next 6-12 months, not enough time for another manufacturer to
by refurb 6y ago
Yup. Moderna doesn’t have much to worry about. Most of the volume of vaccine will be sold in the next 6-12 months, not enough time for another manufacturer to develop the manufacturing capability, validate it and get FDA approval.
Even if new vaccines are needed for new variants, it won’t be easy for another company to catch up when the cycle are 12 months long and then you’re onto the next version.
- thaeli 6y agoPlus, once the pandemic is "over" at least officially, their best case scenario is that other manufacturers did implement their parents.. because they can start collecting license fees, and those manufacturers are likely to have made investments in ways that commit them long-term to using processes covered by Moderna's patent portfolio.
- bluGill 6y agoModerna would probably be happy to license their next vaccine to someone who did invest in a factory. The price would be probably be affordable. I'm not sure it is worth it though, only time will tell if a booster shot is needed.